Leptomycin b l2913
Leptomycin B (L2913) is a laboratory compound supplied by Merck Group. It is a natural product isolated from the bacterium Streptomyces. Leptomycin B is known to inhibit the nuclear export receptor protein Exportin 1 (XPO1 or CRM1).
Lab products found in correlation
5 protocols using leptomycin b l2913
Selective Inhibitors for Cell Research
Selective Inhibitors for Cell Research
Antibodies for Ankrd54 Characterization
Maintenance of HeLa and HCT116 Cells
Antibody Characterization and Reagent Validation
Rhodamine Phalloidin (PHDR1) was from Cytoskeleton (Denver, CO). Epidermal Growth Factor (EGF; cat. 236-EG) was purchased from R&D Systems. Gefitinib (ZD1839) was from Cayman Chemical Company (Ann Arbor, MI). AG-1478 (A8357) and MG-132 (A2585) were from ApexBio (Houston, TX). Cycloheximide (C1988) and leptomycin B (L2913) were purchased from Sigma-Aldrich.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!